Comparing Fasenra vs Trelegy Ellipta
| Fasenra (benralizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|---|
| Fasenra (benralizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
[Fasenra](https://www.drugs.com/fasenra.html) is a biologic that may be used to treat severe eosinophilic asthma in adults and children aged 6 years and older or eosinophilic granulomatosis with... View more |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions Popular comparisons
|
|||||||
| More about Fasenra (benralizumab) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||
| Ratings & Reviews | |||||||||
|
Fasenra has an average rating of 7.8 out of 10 from a total of 76 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.8 out of 10 from a total of 260 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Fasenra side effects |
View all Trelegy Ellipta side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Trelegy Ellipta prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
360 hours |
24 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 25 drugs are known to interact with Fasenra:
|
A total of 540 drugs are known to interact with Trelegy Ellipta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 14, 2017 |
September 18, 2017 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Nucala
Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with ...
Mepolizumab
Mepolizumab is used to treat several eosinophil-related conditions including Hypereosinophilic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.